Acorda Therapeutics, Ardsley, New York, USA
Ron Cohen
Decibel Therapeutics, Boston, Massachusetts, USA
Steven Holtzman
New Milford, Connecticut, USA
Jeremy M Levin
Alnylam Pharmaceuticals, Inc., Cambridge, Massachusetts, USA
John M Maraganore
Quentis Therapeutics, Inc., New York, New York, USA
Michael Aberman
Cydan II, Cambridge, Massachusetts, USA
Chris Adams
Gamida Cell, Boston, Massachusetts, USA
Julian Adams
Blueprint Medicines, Cambridge, Massachusetts, USA
Jeffrey Albers
Veracyte, Inc., South San Francisco, California, USA
Bonnie Anderson
Health Catalysts Group, Tucson, Arizona, USA
Mara G Aspinall
Constellation Pharmaceuticals, Inc., Cambridge, Massachusetts, USA
James E Audia
Principa Biopharma, South San Francisco, California, USA
Martin Babler
Caltech, Pasadena, California, USA
David Baltimore
Moderna, Inc., Cambridge, Massachusetts, USA
Stephane Bancel
Atlas Venture, Cambridge, Massachusetts, USA
Peter Barrett
ZappRx, Boston, Massachusetts, USA
Zoe Barry
MIT/Whitehead Institute, Cambridge, Massachusetts, USA
David Bartel
BioMarin Pharmaceutical, Novato, California, USA
Jean-Jacques Bienaime
Acorda Therapeutics, Inc., Ardsley, New York, USA
Burkhard Blank
Cytokinetics, Inc., South San Francisco, California, USA
Robert I Blum
Equillium, Inc., La Jolla, California, USA
Daniel M Bradbury
Harvard Medical School, Brigham and Women's Hospital, Boston, Massachusetts, USA
Eugene Braunwald
Akebia Therapeutics, Cambridge, Massachusetts, USA
John P Butler
Novo Nordisk (retired), Seattle, Washington, USA
Bruce Carter
Morphic Therapeutic, Waltham, Massachusetts, USA
Gustav Christensen
Atara Biotherapeutics, South San Francisco, California, USA
Isaac Ciechanover
Genocea Biosciences, Inc., Cambridge, Massachusetts, USA
Chip Clark
Cardinal Partners, Princeton, New Jersey, USA
John K Clarke
Flexion Therapeutics, Burlington, Massachusetts, USA
Michael D Clayman
Graybug Vision, Redwood City, California, USA
Jeffrey L Cleland
Lyme Properties 2, LLC, West Lebanon, New Hampshire, USA
David Clem
Yumanity Therapeutics, Cambridge, Massachusetts, USA
N Anthony Coles
Massachusetts Institute of Technology, Cambridge, Massachusetts, USA
Charles L Cooney
MassBio, Cambridge, Massachusetts, USA
Robert K Coughlin
Csimma LLC, Lincoln, Massachusetts, USA
Zoltan Csimma
IRC, CGIR, LLC, Savannah, Georgia, USA
Sally J Curley
Xencor, Monrovia, California, USA
Bassil Dahiyat
ProQR Therapeutics, Cambridge, Massachusetts, USA
Daniel A de Boer
Aura Biosciences Inc., Cambridge, Massachusetts, USA
Elisabet de los Pinos
Department of Cancer Biology, MD Anderson Cancer Center, Houston, Texas, USA
Ronald A DePinho
MaxCyte Inc., Gaithersburg, Maryland, USA
Douglas Doerfler
Dornbusch & Company, Oakland, California, USA
Daniel Dornbusch
Aldeyra Therapeutics, Lexington, Massachusetts, USA
Richard H Douglas
Lundbeck Pharmaceuticals, København, Denmark
Deborah Dunsire
Third Rock Ventures, Boston, Massachusetts, USA
Neil Exter
PaxVax, Redwood City, California, USA
Nima Farzan
Atlas Venture, Cambridge, Massachusetts, USA
Jean-François Formela
Verastem, Inc., Needham, Massachusetts, USA
Robert Forrester
Cambridge BioMarketing, Boston, Massachusetts, USA
Maureen N Franco
Apellis Pharmaceuticals, Crestwood, Kentucky, USA
Cedric Francois
Blaze Bioscience Inc., Seattle, Washington, USA
Heather Franklin
Relypsa, a Vifor Pharma Group Company, Redwood City, California, USA
Scott Garland
Evelo Biosciences, Boston, Massachusetts, USA
Simba Gill
The Column Group, San Francisco, California, USA
David V Goeddel
Trevena Inc., Wayne, Pennsylvania, USA
Maxine Gowen
Intarcia Therapeutics, Boston, Massachusetts, USA
Kurt Graves
Gray Strategic Advisors, LLC, New York, New York, USA
Mary Ann Gray
Alnylam Pharmaceuticals, Cambridge, Massachusetts, USA
Barry Greene
Imbria Pharmaceuticals, Rancho Santa Fe, California, USA
David-Alexandre C Gros
Gossamer Bio, San Diego, California, USA
Faheem Hasnain
Science History Institute, Philadelphia, Pennsylvania, USA
Michael Hammerschmidt
Redpin Therapeutics, New York, New York, USA
Elma S Hawkins
Hydra Biosciences, Cambridge, Massachusetts, USA
Russell Herndon
Nkarta Therapeutics, South San Francisco, California, USA
Paul Hastings
Acorda Therapeutics, Ardsley, New York, USA
Andrew Hindman
Cell Medica, London, UK
Annalisa Jenkins
Dana-Farber Cancer Institute/Harvard Medical School/MIT/Foghorn Therapeutics, Inc., Boston, Massachusetts, USA
Cigall Kadoch
Ultragenyx Pharmaceutical Inc., Novato, California, USA
Emil D Kakkis
ProMIS Neurosciences, Cambridge, Massachusetts, USA
Johanne Kaplan
Alnylam Pharmaceuticals, Inc., Cambridge, Massachusetts, USA
Laurie Keating
GlycoMimetics, Rockville, Maryland, USA
Rachel King
Virion Biotherapeutics LLC, London, UK
Vanessa King
MacroGenics Inc., Rockville, Maryland, USA
Scott Koenig
RA Capital Management, Boston, Massachusetts, USA
Peter Kolchinsky
Insitro, South San Francisco, California, USA
Daphne Koller
Naples, Florida, USA
Marc Kozin
ViaCyte, San Diego, California, USA
Paul Laikind
MIT, Cambridge, Massachusetts, USA
Robert Langer
LaVoieHealthScience, Boston, Massachusetts, USA
Donna L LaVoie
Decibel Therapeutics, Boston, Massachusetts, USA
John J Lee
Deerfield Management, New York, New York, USA
Jonathan Leff
Tasso, Inc., Bellevue, Washington, USA
Alan Levy
Harvard Medical School, Boston, Massachusetts, USA
Judy Lieberman
Alnylam Pharmaceuticals, Cambridge, Massachusetts, USA
Christine Lindenboom
Broad Institute/Howard Hughes Medical Institute/Harvard University, Cambridge, Massachusetts, USA
David R Liu
Assembly Biosciences, San Francisco, California, USA
Uri Lopatin
Global Blood Therapeutics, South San Francisco, California, USA
Ted W Love
MTS Health Partners, New York, New York, USA
David N Low Jr
Scholar Rock, Cambridge, Massachusetts, USA
Nagesh K Mahanthappa
Inspired Purpose Coaching LLC, Canton, Massachusetts, USA
Tony Martignetti
Akili Interactive Labs, Inc., Boston, Massachusetts, USA
W Eddie Martucci
Biocon Pharma Inc., Iselin, New Jersey, USA
Kiran Mazumdar-Shaw
Blueprint Medicines Corporation, Cambridge, Massachusetts, USA
Tracey L McCain
Pear Therapeutics, Boston, Massachusetts, USA
Corey M McCann
Skyworks Solutions, Inc., Woburn, Massachusetts, USA
David J McLachlan
KSQ Therapeutics, Cambridge, Massachusetts, USA
David Meeker
MTS Health Partners, New York, New York, USA
Ravi Mehrotra
Conatus Pharmaceuticals Inc., San Diego, California, USA
Steven J Mento
Third Rock Ventures, Boston, Massachusetts, USA
Rachel Meyers
Visterra Inc., Waltham, Massachusetts, USA
Gregory Miller
Regenxbio Inc., Rockville, Maryland, USA
Ken Mills
Cognition Therapeutics, Inc., Pittsburgh, Pennsylvania, USA
Kenneth I Moch
Exelixis, Inc., Alameda, California, USA
Michael M Morrissey
PTX Partner Therapeutics, Lexington, Massachusetts, USA
Robert Mulroy
Boehringer Ingelheim Pharmaceuticals, Cambridge, Massachusetts, USA
Imran Nasrullah
Sutro Biopharma, Inc., South San Francisco, California, USA
William J Newell
Keryx Biopharmaceuticals, Inc., Boston, Massachusetts, USA
John F Neylan
Vedanta Biosciences, Cambridge, Massachusetts, USA
Bernat Olle
Marblehead, Massachusetts, USA
Eric T Olson
HealthCare Ventures, Cambridge, Massachusetts, USA
Douglas E Onsi
BioVentures/Egalet Corporation, Wayne, Pennsylvania, USA
John E Osborn
Millendo Therapeutics, Inc., Ann Arbor, Michigan, USA
Julia C Owens
Biogen Inc., Cambridge, Massachusetts, USA
Stelios Papadopoulos
Karuna Pharmaceuticals, Boston, Massachusetts, USA
Steve Paul
Visterra, Inc., Cambridge, Massachusetts, USA
Brian J G Pereira
OncoPep, Inc., North Andover, Massachusetts, USA
Doris Peterkin
Third Rock Ventures, Boston, Massachusetts, USA
Cary Pfeffer
Intercept, New York, New York, USA
Mark Pruzanski
Syros Pharmaceuticals, Inc., Cambridge, Massachusetts, USA
Gerald E Quirk
Ardelyx, Inc., Fremont, California, USA
Michael Raab
X4 Pharmaceuticals Inc., Cambridge, Massachusetts, USA
Paula Ragan
Ovid Therapeutics, New York, New York, USA
Amit Rakhit
Grail/Neurocrine Biosciences/Fate Therapeutics/Daré Bioscience/Regulus Therapeutics, Rancho Santa Fe, California, USA
Bill Rastetter
Translate Bio, Lexington, Massachusetts, USA
Ron Renaud
Atlas Venture, Cambridge, Massachusetts, USA
Jason P Rhodes
5AM Ventures, Boston, Massachusetts, USA
Scott M Rocklage
Flagship Pioneering, Cambridge, Massachusetts, USA
Michael Rosenblatt
Synergenics, LLC., San Francisco, California, USA
William J Rutter
Venrock, Palo Alto, California, USA
Camille Samuels
Contravir Pharmaceuticals, Edison, New Jersey, USA
James Sapirstein
Ocular Therapeutix, Bedford, Massachusetts, USA
Amar Sawhney
Harvard University/Massachusetts General Hospital, Boston, Massachusetts, USA
David Scadden
Vir Biotechnology, Inc., San Francisco, California, USA
George Scangos
Geron Corporation, Menlo Park, California, USA
John A Scarlett
Broad Institute/Harvard University, Boston, Massachusetts, USA
Stuart L Schreiber
Lycera Corp., New York, New York, USA
Paul J Sekhri
Seres Therapeutics, Cambridge, Massachusetts, USA
Eric Shaff
Puretech Health, Boston, Massachusetts, USA
Bennett Shapiro
Princeton University, Princeton, New Jersey, USA
Thomas Shenk
Syros Pharmaceuticals, Cambridge, Massachusetts, USA
Nancy Simonian
Deerfield Management, New York, New York, USA
William Slattery
ReNetX Bio, New Haven, Connecticut, USA
Erika R Smith
Equillium, Inc., La Jolla, California, USA
Bruce Steel
CognifiSense, Inc., Park City, Utah, USA
Harald F Stock
OncoResponse, Inc., Seattle, Washington, USA
Clifford J Stocks
Decibel Therapeutics Incorporated, Boston, Massachusetts, USA
Michael Su
Red Sky Partners, Cambridge, Massachusetts, USA
Tim Surgenor
UCB S.A., Brussels, Belgium
Jean-Christophe Tellier
Tracon Pharmaceuticals Inc., San Diego, California, USA
Charles Theuer
Alzheon, Framingham, Massachusetts, USA
Martin Tolar
Scripps Research Translational Institute/Molecular Medicine, La Jolla, California, USA
Eric Topol
Jounce Therapeutics, Inc., Cambridge, Massachusetts, USA
Beth Trehu
Alnylam Pharmaceuticals Inc., Cambridge, Massachusetts, USA
Akshay K Vaishnaw
Bio Point Group, Punta Gorda, Florida, USA
Christi van Heek
Unum Therapeutics Inc., Cambridge, Massachusetts, USA
Michael J Vasconcelles
Navitor Pharmaceuticals, Inc., Cambridge, Massachusetts, USA
George P Vlasuk
Biogen, Cambridge, Massachusetts, USA
Michel Vounatsos
ChEM-H Institute/Stanford University, Stanford, California, USA
Christopher T Walsh
Acorda Therapeutics, Inc., Ardsley, New York, USA
Jane Wasman
MTS Health Partners LP, New York, New York, USA
Andrew Weisenfeld
Ovid Therapeutics, New York, New York, USA
Yaron Werber
TScan Therapeutics, Boston, Massachusetts, USA
Christoph Westphal
Crinetics Pharmaceuticals, San Diego, California, USA
Wendell Wierenga
Scottsdale, Arizona, USA
Terry Winters
ProMIS Neurosciences, Cambridge, Massachusetts, USA
Eugene Williams
Unum Therapeutics Inc., Cambridge, Massachusetts, USA
Chuck Wilson
Syros Pharmaceuticals, Inc., Cambridge, Massachusetts, USA
Peter Wirth
Irras, San Diego, California, USA
Kleanthis Xanthopoulos
Nuvelution Pharma, Inc., South San Francisco, California, USA
Sanford (Sandy) Zweifach